Drugs

Clinical Potential of Insulin Therapy in Critically Ill Patients
pp. 625-636(12)
Authors: Mesotten D.; Berghe G.V.d.

Pharmacological Treatment of Patients with Peripheral Arterial Disease
pp. 637-647(11)
Authors: Kim C.K.; Schmalfuss C.M.; Schofield R.S.; Sheps D.S.

Opioid-Induced Bowel Dysfunction: Pathophysiology and Potential New Therapies
pp. 649-671(23)
Authors: Kurz A.; Sessler D.I.

DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa™)
pp. 673-682(10)
Authors: Curran M.P.; Goa K.L.

DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa™1): A Viewpoint by Heinz-Josef Schmitt
pp. 683-684(2)
Author: Schmitt H-J.

DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa™): A Viewpoint by Scott A. Halperin
pp. 683-684(2)
Author: Halperin S.A.

Lovastatin Extended Release: A Review of its Use in the Management of Hypercholesterolaemia
pp. 685-699(15)
Authors: Curran M.P.; Goa K.L.

Peginterferon--2a (40kD) Plus Ribavirin: A Review of its Use in the Management of Chronic Hepatitis C
pp. 701-730(30)
Authors: Keating G.M.; Curran M.P.